Profil
Breian Knudsen formerly worked at Novo Nordisk A, as Manager and Veloxis Pharmaceuticals A, as Vice President-Technical Operations from 2007 to 2016.
Mr. Knudsen received his graduate degree from the University of Copenhagen.
Ehemalige bekannte Positionen von Breian Knudsen
Unternehmen | Position | Ende |
---|---|---|
VELOXIS PHARMACEUTICALS A/S | Technik-/Wissenschafts-/F&E-Leiter | 01.05.2016 |
NOVO NORDISK A/S | Corporate Officer/Principal | - |
Ausbildung von Breian Knudsen
University of Copenhagen | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
NOVO NORDISK A/S | Health Technology |
Private Unternehmen | 1 |
---|---|
Veloxis Pharmaceuticals A/S
Veloxis Pharmaceuticals A/S Pharmaceuticals: MajorHealth Technology Veloxis Pharmaceuticals A/S is a commercial-stage specialty pharmaceutical company, which engages in the development and commercialization of medicine for the prevention of organ rejection in kidney transplant patients. The company is focused on the direct commercialization of Envarsus XR in the US, expansion of partnerships for markets, and acquisition of assets utilized in transplant patients and by adjacent medical specialties. Veloxis Pharmaceuticals was founded in June 2002 and is headquartered in Copenhagen, Denmark. | Health Technology |